Target intelligence / Profile preview

Novel transcript, antisense to POTEM (ENSG00000276888 (no common abbreviation))

Target
ENSG00000276888 (no common abbreviation)
Molecular classification
Other, non-coding RNA, antisense transcript
01

Overview

"Novel transcript, antisense to POTEM" (ENSG00000276888, LOC101929572) is a predicted non-coding RNA annotated on the human genome, identified by its antisense orientation to the POTEM gene locus. This entry is currently uncharacterized in terms of protein coding potential, molecular function, involvement in human biology, or disease. No publications or curated databases assign it any role as a drug target, biomarker, or clinical relevance. Its annotation as "novel transcript" and "antisense to POTEM" indicates it was predicted by transcriptome sequencing but not yet experimentally validated or functionally described. It does *not* fit established categories such as receptor, enzyme, transporter, or transcription factor, nor does it have a known molecular or disease association. Accordingly, this is *not* a target suitable for drug discovery or therapeutic intervention, and its inclusion as a "target" is likely a result of automated annotation without supporting evidence.

Other names
LOC101929572novel transcript antisense to POTEMENSG00000276888
02

Mechanism of action

Not applicable

03

Biological functions

None establishedfunction unknown
04

Disease associations

None established

Beyond the preview

Go deeper on Novel transcript, antisense to POTEM (ENSG00000276888 (no common abbreviation)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to POTEM (ENSG00000276888 (no common abbreviation)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call